NR3C1 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, researchers have confirmed that the glucocorticoid receptor (GR) can upregulate the expression of PD-L1 and downregulate the expression of MHC-1 in tumor cells, thereby impairing cytotoxic T cells’ infiltration and anti-tumor immune function (114).